Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A shows a slight decrease today, losing -€1.400 (-0.480%) compared to yesterday.
Our community is currently high on Bio-Rad Labs Inc. A with 4 Buy predictions and 0 Sell predictions.
With a target price of 322 € there is a slightly positive potential of 12.67% for Bio-Rad Labs Inc. A compared to the current price of 285.8 €.
Our community identified positive and negative aspects for Bio-Rad Labs Inc. A stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bio-Rad Labs Inc. A stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bio-Rad Labs Inc. A in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Rad Labs Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Rad Labs Inc. A | -0.480% | 2.732% | 11.380% | 30.502% | 10.818% | -24.392% | -54.272% |
| Haemonetics Corp. | 2.840% | 5.797% | 10.606% | - | 6.569% | - | - |
| CONMED Corp. | 0.500% | 7.979% | 42.958% | -6.881% | 16.000% | -62.056% | -64.696% |
| Penumbra Inc | 0.290% | -0.786% | 0.507% | 26.239% | 4.204% | 1.314% | 23.268% |
Comments
Bio-Rad Laboratories (BIO) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $320.00 price target on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank Of Canada from $387.00 to $409.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat